Neurofibromatosis bụ ihe mgbagwoju anya ọtụtụ sistemu mmadụ kpatara ngbanwe nke neurofibromin. Neurofibromatosis na-ebute etuto n'akụkụ sistemu ụjọ nke nwere ike itolite n'ebe ọ bụla na ahụ. Neurofibromatosis bụ otu n'ime ọrịa mkpụrụ ndụ ihe nketa a na-ahụkarị yana nsogbu nke autosomal.
Mgbaàmà ndị a na-ahụkarị nke neurofibromatosis gụnyere ntụpọ na-acha uhie uhie na-acha aja aja na akụkụ anya nke a na-akpọ Lisch nodules na neurofibromas. Scoliosis (mkpụkọ ọkpụkpụ azụ), nkwarụ mmụta, nsogbu ịhụ ụzọ, nkwarụ uche, ọtụtụ cafe au lait spots na epilepsy nwekwara ike iso ya.
Neurofibromatosis type I (NF-1) is a complex multi-system human disorder caused by the mutation of a gene on chromosome 17 that is responsible for production of a protein, called neurofibromin, which is needed for normal function in many human cell types.
☆ Na nsonaazụ Stiftung Warentest nke 2022 sitere na Germany, afọ ojuju ndị ahịa na ModelDerm dị ntakịrị ntakịrị karịa na nyocha telemedicine akwụ ụgwọ.
Cafe au lait macule hụrụ na Neurofibromatosis type 1 (NF-1)
Neurofibromatosis bụ ọnọdụ na-ebute etuto na sistem ụjọ na akpụkpọ ahụ. A na-eketa ụdị 1 nke ukwuu ma gosipụta mgbaàmà dịka neurofibromas, café-au-lait spots, freckling, and optic gliomas. Nchọpụta nyocha dabere na akara ụlọ ọgwụ. Ụdị 2, n'aka nke ọzọ, bụ akara bilateral vestibular schwannomas (VS) and meningiomas , nke eketakwara nke ukwuu. Nlekọta gụnyere nlekota oge na ọgwụgwọ ahụike dịka ọ dị mkpa maka ụdị abụọ neurofibromatosis. Neurofibromatosis is a neurocutaneous disorder characterized by tumors in the nervous system and skin. Neurofibromatosis types 1 and 2 are the most common and are distinct entities. Neurofibromatosis type 1, or von Recklinghausen disease, is an autosomal dominant disease. Neurofibromatosis type 1 presents with neurofibromas, cafe-au-lait macules, freckling, and optic gliomas. It is a clinical diagnosis. Neurofibromatosis type 2 (NF2) is a disease characterized by bilateral vestibular schwannomas (VS) and meningiomas. It has an autosomal dominant inheritance pattern. Treatment for neurofibromatosis types 1 and 2 is clinical monitoring and medical intervention when appropriate.
Mgbaàmà ndị a na-ahụkarị nke neurofibromatosis gụnyere ntụpọ na-acha uhie uhie na-acha aja aja na akụkụ anya nke a na-akpọ Lisch nodules na neurofibromas. Scoliosis (mkpụkọ ọkpụkpụ azụ), nkwarụ mmụta, nsogbu ịhụ ụzọ, nkwarụ uche, ọtụtụ cafe au lait spots na epilepsy nwekwara ike iso ya.
Enweghị ọgwụgwọ a kapịrị ọnụ ka ọ dị ugbu a.